By no means is this an exhaustive list on all the terminology relating to the COVID-19 pandemic. For more information, please refer to the World Health Organisation (WHO) and the Centers for Disease Control and Prevention (CDC). AAdenovirus- a group of related viruses. They were first removed from human adenoid glands (found at the back of the throat), hence the name. Asymptomatic- where a person is infected by the virus but does not present any symptoms. Go Back Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Glossary for COVID-19 terms Last updated: 23/01/25 Published: 28/12/22 Key terms By no means is this an exhaustive list on all the terminology relating to the COVID-19 pandemic. For more information, please refer to the World Health Organisation (WHO) and the Centers for Disease Control and Prevention (CDC). – A Adenovirus- a group of related viruses. They were first removed from human adenoid glands (found at the back of the throat), hence the name. Asymptomatic- where a person is infected by the virus but does not present any symptoms. Can still pass the virus and infection onto others. C Coronavirus- a group of related viruses that cause diseases in mammals and birds. Named after the crown-like spike protein on the virus’s surface- ‘corona’ in Latin for crown. COVID-19/ COVID – the disease that coronavirus causes D DNA- deoxyribonucleic acid, the cell’s code to life. DNA instructs how to make proteins, which are essential for function in the body. Double helix. E Epicentre- the central point of the virus outbreak. This changed during the COVID-19 pandemic depending on the variant of virus. Epidemic- an outbreak in a localised area at a particular time H Herd immunity- when enough people are protected against the disease, that it lends immunity to those who are not protected. Can achieve protection against the disease through either previous infection, and/ or vaccination. I Immunity- achieving immunity means to be protected from future infections by viruses, and bacteria for example. You can achieve immunity through either previous infection, and/ or vaccination. Immunosuppressed- the immune system is suppressed. In other words, people who are immunosuppressed have a reduced ability to fight diseases. Thus preventing them from being infected in the first place is of great importance. Infection- the unnormal invasion of microorganisms into the body. Some infections present symptoms- at least straight away- while others do not show any symptoms. L Lockdown- preventing people from leaving where they are, to stop the transmission and contain the virus in the COVID-19 pandemic. M Mass vaccination- vaccinating many people in a certain area at a particular time mRNA- messenger RNA (ribonucleic acid). Single helix. Acts as a go-between for DNA and the proteins that are being made. P Pandemic- a global, or national outbreak Protein- an important molecule. Used as a fuel source, a building block, a carrier among other things, in the human body. R Restrictions- impeding or hindering movement and travel during the COVID-19 pandemic, in order to contain the spread of the virus and curb transmission. S Shedding- (in biology) refers to viruses casting off viral particles which can then infect others Side effects- effects that are different and potentially harmful from the main, intended effects of a medication, treatment, or vaccine. Examples of some side effects: headaches, aches, pains, fever. Symptomatic- where a person is infected with the virus and does present symptoms. Can still pass the virus and infection onto others. Symptoms- the signs a person has been infected; this can be physical or mental. With COVID-19, you can show symptoms as symptomatic, or not present symptoms as asymptomatic, if infected. Examples of symptoms for COVID-19 include loss of taste and smell, a persistent cough, fever. T Transmission- how a particular disease, in this case coronavirus, is passed from one person to another. V Vaccination- the administration of vaccine into the body. Vaccine- a form of active immunity, where a weakened, live version of the infection agent is administered into the body. The immune system kicks in and destroys the infection agent, but not before taking note of the genetic material (e.g. mRNA or DNA from the protein) from the agent. The immune system will use this genetic material to ‘remember’ the infection next time it appears, so it can prepare a speedier, more efficient response. Vaccine hesitancy- uncertainty as to whether people should take the vaccine. This could be due to a variety of reasons: being unfamiliar with the vaccine and its contents, and/ or being distrusting of the government and those in the health organisation. Viral load- the amount of virus (or viral genetic material) a person has in their body at a particular time. A person not infected with the virus will have no viral load, whereas a person infected with the virus will have a much higher viral load. Virus- a microorganism. Some spread diseases as vectors, while some are ‘better’. To date, it is being argued whether viruses are alive or not. W Wuhan- Capital of Hubei Province in China. First epicentre of coronavirus. Written by Manisha Halkhoree Related article: The origins of COVID-19

Lesser-known illnesses Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Rare zoonotic diseases 29/03/26, 17:06 Last updated: Published: 08/07/23, 14:34 Lesser-known illnesses This is article no. 1 in a series on rare diseases. Next article: Breast cancer in males . Introduction From COVID-19 possibly coming from livestock in Wuhan market to HIV resulting from numerous transmissions between African primates, it seems that zoonotic diseases are difficult to control. They occur when pathogenic microorganisms are spread from animals to humans or vice-versa. Their impact on human civilization is alarming because they are responsible for 2.5 billion cases of illness and 2.7 million deaths in humans annually around the world. Although there is a lot of information regarding more familiar zoonotic diseases such as rabies and malaria, this article focuses on those that may be less discussed as they could become more problematic in the future. Crimean-Congo haemorrhagic fever (virus) To begin, Crimean-Congo haemorrhagic fever (CCHF) is a viral disease, which spreads when humans are bitten by ticks carrying the virus along with farmers killing infected livestock. It is endemic in more than 30 European, African and Asian countries with the exact factors contributing to the increased cases of CCHF being a mystery. Diagnosing the disease involves detecting the virus through Enzyme-linked immunosorbent assay (ELISA), real time polymerase chain reaction (RT-PCR) along with detecting IgM and IgG antibodies using ELISA. As for the treatment options for CCHF, they are finite as there are no available vaccines and the only antiviral drug used against the virus is ribavirin, which prevents replication of various DNA and RNA viruses in-vitro. Given all this information, it is evident that extensive research is necessary to better understand the disease holistically and design drugs that can stop more fatalities associated with CCHF. Trichinellosis (parasite) The next zoonotic disease to address is trichinellosis or trichinosis , which is caused by Trichinella spiralis and so it is a parasitic infection. It can spread by eating poorly prepared meat such as pork, and mammals like horses and wild carnivores are typically the reservoirs of infection. Its epidemiology in humans seems to be limited because it has 10,000 cases and 0.2% death rate annually. Moreover, an important factor that can contribute to the spread of trichinellosis is culture because certain communities have dishes containing raw meat. For example, a review referenced more than 600 outbreaks, 38,797 infections and 336 deaths in humans between 1964 and 2011 in China. As for diagnosing trichinellosis, it is challenging because it has general signs. With this in mind, the common method to spot the disease is detecting IgG antigens that work against Trichinella spiralis . On the other hand, its major drawback is getting a false negative in early trichinellosis infection. Like CCHF, trichinellosis is not as prevalent compared to other zoonotic diseases but it can have devastating impacts on specific countries, so increasing the supply of antiparasitic drugs like albendazole and/or mebendazole would be beneficial to stop the spread of Trichinella spiralis. Brucellosis (bacteria) The next zoonotic disease which is caused by a bacterial pathogen is brucellosis and is common worldwide, though certain places have higher prevalence of the disease compared to others. The pathogen can be transmitted through various ways such as direct contact with infected animal tissue on broken skin and consuming contaminated meat or dairy. Interestingly, it has been linked to childhood pulmonary infections as 18 out of 98 brucellosis patients have experienced such symptoms, but this is rare (based solely on a 2020 study). The graph above indicates that when brucellosis occurs in animals, it has a high likelihood of being passed onto humans. For example, the years 2004-2007 could be when brucellosis cases were most frequent. This could have been alleviated through specific antibiotics used to treat brucellosis that include rifampin, doxycycline and streptomycin. Similar to trichinellosis, brucellosis diagnosis can be difficult because the symptoms can vary and are not exclusive to one disease, suggesting that different laboratory techniques are needed to find brucellosis in patients. Conclusion It looks like there is a recurring pattern of the zoonotic diseases outlined in this article occurring in developing countries as opposed to developed countries. As such, there have to be more effective interventions to prevent their ramifications on populations living in these countries. For this to occur, there has to be sufficient information, awareness, and education of these rarer zoonotic diseases to begin with. Furthermore, the current treatments for CCHF, trichinellosis and brucellosis may be unsuccessful due to the threat of antimicrobial resistance, hence finding alternative treatments for the aforementioned zoonotic diseases is vital in the future. Written by Sam Jarada Related articles: Rabies / Canines and cancer / Vaccine for malaria Project Gallery

A CV entails a person's notable accomplishments. We check your CV for free! Our expert advisors offer to review your CV in a time-efficient manner, by providing quality feedback. Curriculum Vitae (CV) Looking to apply for a job after your graduation, internship, or placement? Read below our CV information and advice! What are CVs? A CV entails a person's notable accomplishments - for example, their education history, work experience, certifications, volunteering experience, projects, and more. They are normally made on Microsoft Word and should be one page long , however someone extremely experienced in their field of work may choose to make their CV as two pages. But isn't this a resumé? ... ... No. CVs contain a more comprehensive breakdown of education, work experience etc; a resum é is not as detailed. A resum é also excludes date of birth, address, and contact info, whereas a CV includes this. Why should you write a good CV? There are several reasons as to why you should write a good CV, with just a few listed below: Professionalism A well organised, polished CV reflects your attention to detail and makes you more likely to be considered by employers for the advertised job. First impression and employability Employers spend less than 9 seconds looking at a CV! Hence, a well-designed CV is important as it will make you stand out and increase chances of securing an interview. Career progression A CV is not only for getting a job. It shows how you have generally developed as an employee, from what new skills you have gained to the responsibilities you have picked up. Networking Having a strong CV will allow you to share your background in a quick and efficient matter at, for example, career fairs or industry events. How do I know if my CV is to the right standard? Read below to find out more. We can check your CV for free! 1. Style We will make sure your writing is coherent and flows in the correct way, such as in chronological order. We will also recommend fonts, font sizes, appropriate headings that employers prefer and more, as layout is incredibly important to consider. 2. Spelling, punctuation and grammar It is easy to make small errors that can be easily overlooked! However, we will proofread your work to make sure your sentences make sense whilst being straight to the point. 3. Sections to include More than one would think, some may include sections that are of no relevance to the employer or put lack of detail in the ones that matter most. We will help make sure you don't fall into this trap. 4. Helping you make a start It is completely normal to feel like you don't know where to start from, too! Our advisors can ask you personalised questions regarding your experience, education, and so on to give you a 'template' to work on. This can then be reviewed and personalised feedback will be given until you are satisfied. 5. Other neat tricks... There are some features of a CV that individuals may not focus on but employers actually look for (hint: super- and extracurricular). Find out more from us if you're interested! Browse some career roles and insights in jobs related to: statistics , nuclear medicine , clinical computer scientist Example universities where some of our advisors attend/have graduated from: Queen Mary University of London, Imperial College London, University of Liverpool and so on. Some of these students have secured placements, internships, and jobs with companies such as GSK and STATIC St. Andrews ! Just like personal statements , our expert advisors offer to review your CV in a time-efficient manner, by providing feedback on the following: Fill the form out below and we will contact you* * Alternatively, you can email us at scientianewsorg@gmail.com . Please keep the subject as 'CVs'. Email Subject Your message Send Thanks for submitting!

The unique condition of microgravity Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Astronauts in space… losing gravity, losing immunity? 26/04/26, 15:42 Last updated: Published: 08/09/24, 14:39 The unique condition of microgravity Introduction Since the first successful human launch to space on April 12th, 1961, over 600 astronauts have travelled beyond the Earth’s atmosphere. Space travel is essential in driving technological innovation and consistently increases our understanding of the cosmos. However, alongside the thrill of space exploration, astronauts face significant challenges, including profound risks to their immune systems. Astronauts in space endure a unique condition of near weightlessness known as microgravity, which often causes dysregulation of their immune systems. Effect of microgravity on T-cell immunity One of the critical studies emphasising the effects of microgravity on the immune system is a twin study conducted by NASA, where they compared various gene expression datasets between an astronaut who had been on the International Space Station (ISS) for one year and their identical twin who had not travelled to space. They discovered changes in the methylation patterns of immunologically relevant genes such as NOTCH3 and SLC1A5 , which are both crucial in T cell development. They also found microgravity caused an increase in pro-inflammatory molecules and decreased anti-inflammatory molecules, alluding to spaceflight causing an increased inflammatory state. These patterns are consistent with other experiments simulating microgravity conditions, such as prolonged bed rest models. Microgravity has also been shown to induce thymic atrophy, which is when the thymus slowly shrinks and loses its function. The thymus is a primary lymphoid organ that is crucial in T cell development. An experiment performed on the International Space Station (ISS) has shown that exposing mice to 1g gravity can alleviate microgravity-induced thymic atrophy ( Figure 1 ), suggesting that exposure to a standard gravitational field is a potential treatment. The thymic environment is altered due to microgravity. In particular, thymic epithelial cells (TECs) are misplaced and, therefore cannot perform their role in T cell maturation. Overall, there is a significant decrease in the output of T cells from the thymus, shown by a clear decrease in thymic mass and alterations in gene expression related directly to the process of T cell differentiation. Effect of microgravity on the bone marrow Furthermore, microgravity affects the bone marrow, another primary lymphoid organ. The bone marrow consists of many mesenchymal stem cells (MSCs), which differentiate hematopoietic stem cells (HSCs) into leukocytes. Microgravity inhibits osteogenesis and promotes adipogenesis, which means that bone formation is slowed down, but fat cell production is increased. This happens due to the changes to the structure inside the cell, known as actin cytoskeleton, which affects transcriptional regulators, which generally control cell differentiation. In space, there is also suppression of the cytokine CXCL2 in MSCs, which affects HSC differentiation into immune cells, indicating a link between MSC dysfunction and immunosuppression faced by astronauts. Other factors affecting the immune system Microgravity is the main factor behind immune system dysregulation in astronauts, but other factors, such as stress and exposure to cosmic radiation, also play a role. Cosmic radiation can damage DNA, leading to mutations that impair the immune system’s ability to function properly. Stress hormones are known to affect immune system function. For instance, cortisol can reduce the number of leukocytes in circulation. Conclusion Due to the compromised state of the astronauts’ immune systems, latent viruses often reactivate. Herpes viruses, such as varicella-zoster virus (chickenpox!) and Epstein-Barr virus, have been documented to be reactivated in astronauts during and after space flight. This is mainly due to the loss of T cell immunity ( Figure 2 ) and a reduction in NK cell potency and number. Microgravity affects NK cells by changing their cytoskeletal form, which they need to perform cytotoxic functions. Understanding and mitigating the risks of space travel is crucial as more prolonged and ambitious missions are planned, such as sending humans to Mars. The primary medical countermeasure for the reactivation of herpes viruses is re-vaccination. However, at this current point, only a vaccine for varicella-zoster virus is available. Future research focusing on artificial gravity and environmental changes on spacecraft and the ISS may provide a safer journey for astronauts spending extended time in space. Written by Devanshi Shah Related articles: AI in space / The role of chemistry in space / Colonisation of Mars / Artemis: the lunar south pole base REFERENCES Akiyama, T., Horie, K., Hinoi, E., Hiraiwa, M., Kato, A., Maekawa, Y., Takahashi, A. & Furukawa, S. (2020) How does spaceflight affect the acquired immune system? npj Microgravity. 6 (1), 1–7. doi:10.1038/s41526-020-0104-1. Simon N. Archer, Carla Möller-Levet, María-Ángeles Bonmatí-Carrión, Emma E. Laing, Derk-Jan Dijk. Extensive dynamic changes in the human transcriptome and its circadian organization during prolonged bed rest -ScienceDirect. https://www-sciencedirect.com.iclibezp1.cc.ic.ac.uk/science/article/pii/S2589004224005522?via%3Dihub [Accessed: 16 August 2024]. Hicks J, Olson M, Mitchell C, Juran CM, Paul AM. The Impact of Microgravity on Immunological States. Immunohorizons. 2023 Oct 1;7(10):670-682. doi: 10.4049/immunohorizons.2200063. PMID: 37855736; PMCID: PMC10615652. The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight | Science. https://www.science.org/doi/10.1126/science.aau8650 [Accessed: 16 August 2024]. Hicks, J., Olson, M., Mitchell, C., Juran, C.M. & Paul, A.M. (2023) The Impact of Microgravity on Immunological States. ImmunoHorizons. 7 (10), 670–682. doi:10.4049/immunohorizons.2200063. Hobbs, Z. (2023) How many people have gone to space? | Astronomy.com. Astronomy Magazine. https://www.astronomy.com/space-exploration/how-many-people-have-gone-to-space/ . Mehta, S.K., Laudenslager, M.L., Stowe, R.P., Crucian, B.E., Feiveson, A.H., Sams, C.F. & Pierson, D.L. (2017) Latent virus reactivation in astronauts on the international space station. npj Microgravity. 3 (1), 1–8. doi:10.1038/s41526-017-0015-y. Surrey, U. Microgravity found to cause marked changes in gene expression rhythms in humans. https://phys.org/news/2024-03-microgravity-gene-rhythms-humans.html [Accessed: 16 August 2024]. Project Gallery

The human race has witnessed ten influenza pandemics over the course of 300 years. COVID-19, the most recent, killed approximately 6.9 million people and infected nearly 757 million. Go Back Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The world vs the next pandemic Last updated: 01/03/26 Published: 25/03/23 The human race has witnessed ten influenza pandemics over the course of 300 years. COVID-19, the most recent, killed approximately 6.9 million people and infected nearly 757 million. Though seemingly quite large, the number of deaths caused by the coronavirus is still comparatively fewer than the pandemics of the past, which have killed around 50–100 million people globally. These large numbers may seem like statistics from a century ago, but many scientists predict the same-scale destruction with future pandemics, heightening the concern about how prepared we are when the next big outbreak strikes. It is impossible to know when the next pandemic will hit or the number of casualties it will bring. The only certainty is that it cannot be avoided, which raises the question of how to mitigate the impact and reduce the effectiveness of large-scale losses. During the COVID-19 outbreak, we observed that preventive measures such as social distancing and face coverings could intervene in viral transmission to some degree. Additionally, strategies like complete lockdown, isolation and timely treatment can help in the containment and recovery of those already infected. These measures, however, can only be taken once the threat is detected promptly before infecting a larger population. To prevent an infection from becoming an outbreak, strategies that focus on the source of the disease can prove to be highly advantageous. Preventive measures may include: ● monitoring the mobilisation of wildlife that potentially carries harmful pathogens ● studying the interactions between different species in wildlife ● surveillance of the domestic and international markets for wildlife trade and strict imposition of biosecurity laws. Additionally, an effort needs to be made for sharing the generated data with global laboratories to promote scientific collaboration. Once the threat is identified, quick decision-making using the correct precautions needs to take place. Simultaneously, investments in research sectors promoting mRNA vaccine developments, novel drug treatments, and emerging technological advances need to be increased. In conclusion, the strategies for the management of the next pandemic need to operate on a multi-level governance with optimal coordination between different institutions involved in crisis management. There is a constant threat of pandemics looming over the world. The outbreak is inevitable, but its effect solely depends on the preparedness and response of the governmental bodies and global health institutions. Is it going to be a hurricane of destruction, or will it just pass by like a gush of wind? Only time will tell. Written by Navnidhi Sharma Related articles: Diabetes mellitus as an epidemic / Are pandemics becoming less severe? REFERENCES Coccia, M. (2021). Pandemic Prevention: Lessons from COVID-19. Encyclopedia, 1(2), 433–444. https://doi.org/10.3390/encyclopedia1020036 Cockerham, W. C., & Cockerham, G. B. (2021). The COVID-19 reader: the science and what it says about the social. Routledge. Frieden, T. R., Buissonnière, M., & McClelland, A. (2021). The world must prepare now for the next pandemic. BMJ Global Health, 6(3), e005184. https://doi.org/10.1136/bmjgh-2021-005184 Garrett, L. (2005). The Next Pandemic. Foreign Af airs, 84, 3. https://heinonline.org/HOL/LandingPage?handle=hein.journals/fora84&div=61&id=&page= WORLD HEALTH ORGANISATION. (2022). WHO Coronavirus (COVID-19) Dashboard. Covid19.Who. int. https://covid19.who.int/?mapFilter=deaths World Economic Forum. (2021, November 30). COVID-19: How much will it cost to prepare the world for the next pandemic? World Economic Forum. https://www.weforum.org/agenda/2021/11/preparing-for-next-pandemic-covid-19

The specific research that was recognised for a Nobel Prize in Physics was the discovery of radioactivity. Radioactivity is the spontaneous emission of energy, in the form of radiation, a term that Curie herself coined. Marie Curie researched whether uranium, a weakly radioactive element, was found in other materials. She then analysed pitchblende, Go Back Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The Women who have won the Nobel Prize in Physics Last updated: 31/03/26 Published: 01/03/23 March is International Women’s month, so it seems like the perfect time to celebrate the women who have been awarded Nobel Prizes in Physics. There have only been a total of four women to receive this prestigious award, namely Marie Curie, Maria Goeppert Mayer, Donna Strickland, Andrea Ghez, and Anne L’Huillier. This article will detail the research each woman did to achieve the Nobel Prize, as well as the context of their discoveries. Pictured from left to right: Marie Curie, Maria Goeppert Mayer, Donna Strickland, Andrea Ghez and Anne L’Huillier. Marie Curie (1903) Arguably the most famous of these Nobel Prize winners, Marie Curie won her award for research on radioactive phenomena. Curie received half the Nobel Prize for Physics, shared with her husband, but at first, the committee had only intended to award it to him. This was the first Nobel Prize for Physics ever awarded to a woman. The specific research that was recognised for a Nobel Prize in Physics was the discovery of radioactivity. Radioactivity is the spontaneous emission of energy, in the form of radiation, a term that Curie herself coined. Marie Curie researched whether uranium, a weakly radioactive element, was found in other materials. She then analysed pitchblende, a mineral made partially of uranium but had a higher amount of radiation. Curie investigated other elements that pitchblende could be made up of and, as a result of this, discovered new elements: polonium and radium. Following this, she had ambitions of obtaining pure radium, and following this achievement, she was awarded the Nobel Prize in Physics in 1903. Maria Goeppert Mayer (1963) 60 years after Marie Curie was awarded her Nobel Prize for Physics, Maria Goeppert Mayer became the second female recipient. She received the Prize for her work in 1963 on the nuclear shell model of the atomic nucleus. Goeppert Mayer shared her award with two other physicists who came to the same conclusion as her. The nuclear shell model describes the exact makeup of the atomic nucleus, through the exact numbers of protons and neutrons. Maria Goeppert Mayer’s mathematical work on this model described why there are certain amounts of neutrons and protons in stable atoms. She beautifully described the model in terms of waltzers dancing and spinning in circles. Donna Strickland (2018) The next female Nobel Prize in Physics award winner wouldn’t be until another half-century later, with Donna Strickland. Strickland was awarded the Prize for her work on chirped pulse amplification and its applications. Although the research itself was published in 1985, she didn’t receive the award until 2018. Chirped pulse amplification (CPA) is a technique that takes a very short laser pulse (a light flash) and makes it brighter. The technique is useful for making extremely precise cuts, so is used for many laser-related applications, such as laser eye surgery. The wide range of uses CPA has in medicine makes this an important discovery for physics which led to Strickland being awarded the Nobel Prize award. Andrea Ghez (2020) The result of the work of Andrea Ghez, the fourth female Nobel Prize in Physics recipient, may be the most exciting of the research described in this article, particularly for those interested in astrophysics. Ghez won the award for her role in discovering a black hole in the centre of our galaxy. A black hole is a very dense, compact object with gravity so strong that not even light can escape it. Until recently, physicists have not been able to visually observe black holes but instead can detect them by looking at how other objects, such as stars, behave around one. Andrea Ghez and her team used the movement of Sagittarius A* to prove that there was a black hole in the centre of the Milky Way. Anne L'Huillier (2023) The most recent female Nobel Prize in Physics recipient is Anne L’Huillier who, alongside two colleagues, was presented this award for “experimental methods that generate attosecond pulses of light for the study of electron dynamics in matter,” according to the Nobel Prize organisation. What this means is that Dr. L’Huillier created a new and effective method for studying the behaviour of electrons inside atoms. By generating pulses of light each attosecond (a billionth of a billionth of a second), she is able to capture snapshots of electrons over time, allowing scientists to gain a better understanding of these particles. This has been deemed a huge breakthrough because electron dynamics are at the core of processes that create and maintain life. Written by Madeleine Hales Related articles: Female Nobel prize winners in chemistry / African-American women in cancer research

The maths behind trading Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link A comprehensive guide to the Relative Strength Index (RSI) 08/07/25, 15:37 Last updated: Published: 27/12/23, 11:02 The maths behind trading In this piece, we will delve into the essential concepts surrounding the Relative Strength Index (RSI). The RSI serves as a gauge for assessing the strength of price momentum and offers insights into whether a particular stock is in an overbought or oversold condition. Throughout this exploration, we will demystify the underlying calculations of RSI, explore its significance in evaluating market momentum, and unveil its practical applications for traders. From discerning opportune moments to buy or sell based on RSI values to identifying potential shifts in market trends, we will unravel the mathematical intricacies that underpin this critical trading indicator. Please note that none of the below content should be used as financial advice, but for educational purposes only. This article does not recommend that investors base their decisions on technical analysis alone. As indicated in the name, RSI measures the strength of a stock's momentum and can be used to show when a stock can be considered over- or under-bought, allowing us to make a more informed decision as to whether we should enter a position or hold off until a bit longer. It’s all very well and good to know that ‘you should buy when RSI is under 30 and sell when RSI is over 70' , but in this article, I will attempt to explain why this is the case and what RSI is really measuring. The calculations The relative strength index is an index of the relative strength of momentum in a market. This means that its values range from 0 to 100 and are simply a normalised relative strength. But what is the relative strength of momentum? Initial Average Gain = Sum of gains over the past 14 days / 14 Initial Average Loss = Sum of losses over the past 14 days / 14 Relative strength is the ratio of higher closes to lower closes. Over a fixed period of usually 14 days (but sometimes 21), we measure how much the price of the stock has increased in each trading day and find the mean average between them. We then repeat and do the same to find the average loss. The subsequent average gains and losses can then be calculated: Average Gain = [(Previous Avg. Gain * 13) + Current Day's Gain] / 14 Average Loss = [(Previous Avg. Loss * 13) + Current Day's Loss] / 14 With this, we can now calculate relative strength! Therefore, if our stock gained more than it lost in the past 14 days, then our RS value would be >1. On the other hand, if we lost more than we gained, then our RS value would be <1. Relative strength tells us whether buyers or sellers are in control of the price. If buyers were in control, then the average gain would be greater than the average loss, so the relative strength would be greater than 1. In a bearish market, if this begins to happen, we can say that there is an increase in buyers’ momentum; the momentum is strengthening. We can normalise relative strength into an index using the following equation: Relative Strength= Average Gain / Average Loss Traders then use the RSI in combination with other techniques to assess whether to buy or sell. When a market is ranging, which means that price is bouncing between support and resistance (has the same highs and lows for a period), we can use the RSI to see when we may be entering a trend. When the RSI is reaching 70, it is an indication that the price is being overbought, and in a ranging market, there is likely to be a correction and the price will fall so that the RSI stays at around 50. The opposite is likely to happen when the RSI dips to 30. Price action is deemed to be extreme, and a correction is likely. It should, however, be noted that this type of behaviour is only likely in assets presenting mean-reversion characteristics. In a trending market, RSI can be used to indicate a possible change in momentum. If prices are falling and the RSI reaches a low and then, a few days later, it reaches a higher low (therefore, the low is not as low as the first), it indicates a possible change in momentum; we say there is a bullish divergence. Divergences are rare when a stock is in a long-term trend but is nonetheless a powerful indicator. In conclusion, the relative strength index aims to describe changes in momentum in price action through analysing and comparing previous day's highs and lows. From this, a value is generated, and at the extremes, a change in momentum may take place. RSI is not supposed to be predictive but is very helpful in confirming trends indicated by other techniques. Written by George Chant Project Gallery

Landing on the moon (again!) Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Artemis: the Lunar South Pole Base 01/04/26, 12:19 Last updated: Published: 13/01/24, 15:44 Landing on the moon (again!) Humans have not visited the moon since 1972, but that’s about to change. Thanks to NASA’s Artemis missions, we have already taken the first small step towards our own lunar home for astronauts. NASA has established the second generation of its lunar missions- “Artemis”, fittingly named after the ancient Greek Goddess of the Moon, and Apollo’s twin. The ultimate aim of the Artemis missions is to solidify a stepping stone to Mars. Technologies will be developed, tested, and perfected, before confidence is built to travel on to Mars. NASA has to consider the natural conditions of the Moon, since doing so will allow astronauts to limit their reliance on resources from Earth, and increase their length of stay and therefore potential for research. The amount achieved would be extremely limited if a lunar mission relied solely on resources from Earth, due to the limitation of rocket payloads. This is known as In-Situ Resource Utilisation, and in addition to extended lunar stays, its success on the Moon is essential if we hope to one day establish a base on Mars. As a priority, astronauts need to have access to energy and water. Luckily, the conditions at the lunar south pole may be ideal for this. Unlike Earth, where we experience seasons due to its 23.5° tilt, the Moon’s tilt is tiny, at only 1.5°. This means some areas at the lunar poles are almost always exposed to sunlight, providing a reliable source of solar energy generation for a potential Artemis Base Camp. And since the Sun is always near the horizon at the poles, there are even areas in deep craters that never see the light. These areas of “eternal darkness” can reach temperatures of -235°, possibly allowing astronauts access to water ice. Aside from access to resources, Artemis has to consider the dangers that come from living in space. Away from the safety of Earth’s protective atmosphere and magnetosphere, astronauts would be exposed to harsh solar winds and cosmic rays. To combat this, NASA hopes to make use of the terrain surrounding the base, highlighting another advantage of the hilly south pole. The exact location for the Artemis Base is currently undecided. We just know it will most likely be near a crater rim by the south pole, and on the Earth-facing side to allow for communication to and from Earth. Not only is the south pole ideal from a practical standpoint, it is also an area of exciting scientific interest. Scientists will have access to the South Pole–Aitken basin, not only the oldest and largest confirmed impact crater on the Moon, but the second largest confirmed impact crater in the entire Solar System. With a depth of up to 8.2 km, and diameter of 2500 km, it is thought this huge crater will contain exposed areas of lower crust and mantle, providing an insight into the Moon’s history and formation. Additionally, thanks to areas of “eternal darkness” the ice water found deep within craters at the south pole may hold trapped volatiles up to 3.94 billion years old, which, although not as ancient as previously expected, can still provide an insight into the evolution of the Moon. The scientific potential of the Artemis Base Camp extends far beyond location specific investigations to our most fundamental understanding of physics, from Quantum Physics to General Relativity. Not to mention the astronauts themselves, as well as “model organisms” which will be the focus of physiological studies into the effects of extreme space environments. Artemis Timeline Overview Artemis 1 launched on 16th November 2022. It successfully tested the use of two key elements of the Artemis mission- Orion and the Space Launch System (SLS)- with an orbit around the moon. Orion, named after the Goddess Artemis' hunting partner, is the spacecraft that will carry the Artemis crew into lunar orbit. It is carried by the SLS, NASA’s super heavy-lift rocket, one of the most powerful rockets in the world. The original plans to launch Artemis 2 in late 2024 were delayed due to a helium flow issue in the rocket’s upper section. These technical issues pushed the launch date for the first crewed Artemis mission back to 1st April 2026. This 10-day journey includes a lunar flyby, bringing the four astronauts further than humans have ever travelled beyond Earth. Artemis 3 is planned for mid-2027. This mission, no longer crewed, will be a low-Earth orbit, aiming to test important technologies and equipment. Artemis 4 plans to launch in 2028. The mission will include the first use of Gateway, another key element to the Artemis missions. Gateway will be a multifunctional lunar space station, designed to transfer astronauts between Orion and HLS, as well as hosting astronauts to live and research in lunar orbit. Gateway will be constructed over Artemis 4-6 , with each mission completing an additional module. NASA plans to have Artemis missions extending for years beyond this, with over 10 proposed and more expected. Eventually we will have a working base on the Moon with astronauts able to stay for months at a time. Having already started a year ago, Artemis will continue to expand our horizons. We can look forward to uncovering long held secrets of the Moon, and soon, setting our sights confidently on Mars. Written by Imo Bell Related articles: Exploring Mercury / Fuel for the colonisation of Mars / Nuclear fusion REFERENCES How could we live on the Moon? - Institute of Physics. Available at: https://www.iop.org/explore-physics/moon/how-could-we-live-on-the-moon Understanding Physical Sciences on the Moon - NASA. Available at: https://science.nasa.gov/lunar-science/focus-areas/understanding-physical-sciences-on-themoon NASA’s Artemis Base Camp on the moon will need light, water, elevation - NASA. Available at: https://www.nasa.gov/humans-in-space/nasas-artemis-base-camp-on-the-moon-will-need-light-water-elevation Zuber, M.T. et al. (1994) ‘The shape and internal structure of the Moon from the Clementine Mission’, Science, 266(5192), pp. 1839–1843. doi:10.1126/science.266.5192.1839. Flahaut, J. et al. (2020) ‘Regions of interest (ROI) for future exploration missions to the Lunar South Pole’, Planetary and Space Science, 180, p. 104750. doi:10.1016/j.pss.2019.104750. Moriarty, D.P. et al. (2021) ‘The search for lunar mantle rocks exposed on the surface of the Moon’, Nature Communications, 12(1). doi:10.1038/s41467-021-24626-3. Estimates of water ice on the Moon get a ‘dramatic’ downgrade - Physics World. Available at: https://physicsworld.com/a/estimates-of-water-ice-on-the-moon-get-a-dramatic-downgrade Biological Systems in the lunar environment - NASA. Available at: https://science.nasa.gov/lunar-science/focus-areas/biological-systems-in-the-lunar-environme Https://www.nasa.gov/wp-content/uploads/static/artemis/NASA : Artemis - NASA. Available at: https://www.nasa.gov/specials/artemis Project Gallery

Lung cancer can be defined as the uncontrollable growth of abnormal epithelial cells that make up the lung. Smoking is known to be a main risk factor of lung cancer being responsible for at least 70% of lung cancer cases. Go back Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Smoking cessation interventions Last updated: 01/03/26 Published: 10/03/23 Lung cancer can be defined as the uncontrollable growth of abnormal epithelial cells that make up the lung. Smoking is known to be a main risk factor of lung cancer being responsible for at least 70% of lung cancer cases. Burning cigarettes release multiple mutagens and carcinogens which are absorbed and metabolised by the body to cause cancer. The incidence of lung cancer is increasingly becoming worrying due to its high preventability rate of 79% according to the National Cancer Research Institute. This highlights the importance of reducing the incidence of lung cancer and consequently the deaths caused by it and the burden on the NHS and economy. There recently has been a surge in the use of E-cigarettes in comparison to cessation clinics as a cessation tool to prevent lung cancer. Clearly, there is a need to determine the effectiveness of E-cigarettes being used as a smoking cessation tool. Over the years researchers have investigated different cessation techniques such as specialist clinics, therapy, and patches. The purpose of this research was to evaluate the effectiveness of e-cigarettes as a smoking cessation tool to prevent cancer in primary care. The research suggests that E-cigarettes are more commonly and successfully being used as an effective smoking cessation tool in primary care. The research also suggests that the implementation of smoking cessation clinics has helped to reduce the prevalence of smoking. Both E-cigarettes and smoking cessation clinics are useful in reducing the prevalence of smoking and therefore the incidence of lung cancer. However, it is important to acknowledge some of the carcinogens that E-cigarettes possess such as nicotine which can adversely promote cancer growth. This begs the question of the efficacy of E-cigarettes in reducing lung cancer incidence. Predominantly not smoking at all remains the safest option to reduce the chances of lung cancer. Nonetheless, the reduction in funding for Smoking Cessation clinics in primary care should be reviewed given that it was an effective enough strategy in reducing lung cancer incidence. More research (particularly longitudinal studies) is also required into the efficacy of E-cigarettes in reducing lung cancer incidence and the potential long-term effects they could have. Written by Latilda Ajani Related articles: Genetics of excessive smoking and drinking / Smoking and trigeminal neuralgia

...In the nerve fibre world Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Squids are size champions 11/07/25, 10:53 Last updated: Published: 29/06/23, 10:33 ...In the nerve fibre world A cephalopod adventure When you think of squids, you probably imagine them swimming through the ocean and using tentacles to catch their prey. Scientists might not! These slimy sea creatures have helped us to study and understand how our own nervous system works. That’s right, squids are more than just tasty seafood. Squids have a giant axon, which is a single nerve fiber that is much larger than the axons found in other animals, including humans. This giant axon can be up to one millimeter in diameter , which is big enough to be seen with the naked eye. If you’re thinking that 1 millimeter is still pretty small, consider that human axons are measured in micrometers (µm) , so the squid’s giant axons are almost one thousand times larger in diameter than ours . In case you’re wondering what an axon is, it’s the long projection of a neuron that conducts electrical impulses away from the cell body. The electrical impulses generated during an action potential travel down the axon and make their way to the synapse. So the axon is a vital component of the nervous system that helps facilitate communication between neurons and other cells. In 1963, the English scientists Hodgkin and Huxley were awarded the Nobel Prize for their groundbreaking experiments on squid giant axons. Through their work, they provided a detailed understanding of the electrical properties of axon membranes and the role of ion channels in generating and propagating nerve impulses. They also discovered that the giant axon is surrounded by a thick layer of insulation called myelin , which speeds up the transmission of nerve impulses. Their research has been fundamental to the development of modern neurophysiology. So, the next time you enjoy a plate of calamari, remember that the squid on your plate might have contributed to our understanding of the nervous system. Written by Viviana Greco Related article: Frog nerves Project Gallery